Literature DB >> 23058483

Factors associated with high healthcare resource utilisation among COPD patients.

Cayo García-Polo1, Bernardino Alcázar-Navarrete, Luis Alberto Ruiz-Iturriaga, Alberto Herrejón, José Antonio Ros-Lucas, Patricia García-Sidro, Gema Tirado-Conde, José Luis López-Campos, Carlos Martínez-Rivera, Joaquin Costán-Galicia, Sagrario Mayoralas-Alises, Javier De Miguel-Díez, Marc Miravitlles.   

Abstract

BACKGROUND: Chronic obstructive pulmonary disease (COPD) places a huge economic burden on healthcare systems, especially patients with frequent exacerbations and co-morbidities.
OBJECTIVES: To identify factors associated with high utilisation of healthcare resources in a population of patients with COPD.
METHOD: We conducted an observational, cross-sectional, multicentre study with the aim of identifying the factors associated with high resource utilisation among patients with COPD. Sociodemographic and anthropometric characteristics of the study population, as well as data on health-related quality of life, respiratory symptoms, presence of anxiety and depression, physical activity and lung function were collected. We examined the relationship between these variables and high utilisation of healthcare resources, by performing a multivariate analysis based on a logistic regression model.
RESULTS: 115 patients (64 were high users of healthcare resources, and 51 control patients) from 13 hospitals were selected. Patients presenting high resource utilisation had worse FEV₁, worse basal SpO₂, less distance walked in the 6-minute walk test, and increased dyspnoea. They also had a worse BODE index, worse scores in all dimensions of the EURO-QOL 5D and the LCADL scale, and displayed a higher prevalence of depression. Multivariate analysis yielded a statistically significant association between SpO₂, LCADL scores, serum fibrinogen values and total leukocyte count, and high healthcare resource utilisation.
CONCLUSIONS: COPD patients who incur higher healthcare resource utilisation show reduced physical activity, increased respiratory failure and increased systemic inflammation.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23058483     DOI: 10.1016/j.rmed.2012.09.009

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  26 in total

1.  Does roflumilast improve dyspnea in patients with chronic obstructive pulmonary disease? A meta-analysis.

Authors:  Lei Pan; Yong-Zhong Guo; Bo Zhang; Jun-Hong Yan
Journal:  J Thorac Dis       Date:  2013-08       Impact factor: 2.895

2.  Trends in self-rated health status and health services use in COPD patients (2006-2012). A Spanish population-based survey.

Authors:  Javier de Miguel Díez; Rodrigo Jiménez García; Valentín Hernández Barrera; Luis Puente Maestu; Maria Isabel Del Cura González; Manuel Méndez Bailón; Pilar Carrasco Garrido; Ana López de Andrés
Journal:  Lung       Date:  2014-12-31       Impact factor: 2.584

3.  Factors Associated with Depression in COPD: A Multicenter Study.

Authors:  Carlos Martinez Rivera; Joaquín Costan Galicia; Bernardino Alcázar Navarrete; Cayo Garcia-Polo; Luis Alberto Ruiz Iturriaga; Alberto Herrejón; Jose Antonio Ros Lucas; Patricia García-Sidro; Gema Tirado-Conde; Jose Luis López-Campos; Sagrario Mayoralas Alises; Javier de Miguel-Díez; Cristina Esquinas; Marc Miravitlles
Journal:  Lung       Date:  2016-03-01       Impact factor: 2.584

4.  Emotional Intelligence: A Novel Outcome Associated with Wellbeing and Self-Management in Chronic Obstructive Pulmonary Disease.

Authors:  Roberto P Benzo; Janae L Kirsch; Megan M Dulohery; Beatriz Abascal-Bolado
Journal:  Ann Am Thorac Soc       Date:  2016-01

5.  Clinical outcomes and cost analysis of exacerbations in chronic obstructive pulmonary disease.

Authors:  Marc Miravitlles; Cayo García-Polo; Adolfo Domenech; Gustavo Villegas; Francisco Conget; Cristian de la Roza
Journal:  Lung       Date:  2013-07-11       Impact factor: 2.584

6.  Medication Use Before and After Hospitalization for Chronic Obstructive Pulmonary Disease in a Cohort of Elderly Patients with a Medicare Advantage Plan.

Authors:  Qingqing Xu; Sarah S Laxa; Omar Serna; Sujit S Sansgiry
Journal:  Am Health Drug Benefits       Date:  2020-02

7.  SCGB3A2 Inhibits Acrolein-Induced Apoptosis through Decreased p53 Phosphorylation.

Authors:  Reiko Kurotani; Reika Shima; Yuki Miyano; Satoshi Sakahara; Yoshie Matsumoto; Yoko Shibata; Hiroyuki Abe; Shioko Kimura
Journal:  Acta Histochem Cytochem       Date:  2015-04-24       Impact factor: 1.938

8.  Cost-Effectiveness of Domiciliary High Flow Nasal Cannula Treatment in COPD Patients with Chronic Respiratory Failure.

Authors:  Sabrina Storgaard Sørensen; Line Hust Storgaard; Ulla Møller Weinreich
Journal:  Clinicoecon Outcomes Res       Date:  2021-06-18

9.  Predictors of cost-effectiveness of selected COPD treatments in primary care: UNLOCK study protocol.

Authors:  Job F M van Boven; Miguel Román-Rodríguez; Janwillem W H Kocks; Joan B Soriano; Maarten J Postma; Thys van der Molen
Journal:  NPJ Prim Care Respir Med       Date:  2015-08-06       Impact factor: 2.871

10.  Prognostic value of C-reactive protein, leukocytes, and vitamin d in severe chronic obstructive pulmonary disease.

Authors:  Mia Moberg; Jørgen Vestbo; Gerd Martinez; Peter Lange; Thomas Ringbaek
Journal:  ScientificWorldJournal       Date:  2014-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.